Abbott RealTime SARS-C0V-2 assay
CURBING THE COVID-19 OUTBREAK IN REALTIME
Receive your quote directly from the manufacturer.
Abbott real time is a highly effective molecular biology device with reliable results
Molecular biology
Abbott real time is a highly effective molecular biology device with reliable results. Abbott real time with Abbott m2000, make the equipment one of the best molecular biology equipment
Review Date: 27 Jun 2023 | Abbott
Awesome value
Diagnosis
Exceptionally easy to use and very repeatable results
Review Date: 15 Jun 2021 | Abbott
The Abbott RealTime SARS-C0V-2 assay is an Emergency Use Authorization (EUA) test authorized by the U.S. FDA for use by authorized laboratories, using real-time (RT) polymerase chain reaction (PCR) technology for the qualitative detection of nucleic acids from the SARS-CoV-2 virus and diagnosis of SARS-CoV-2 virus infection from individuals meeting CDC clinical and/or epidemiological testing criteria.
Abbott RealTime SARS-CoV-2 assay provides a fully automated solution to help laboratories address the urgent need for automated, high-volume patient testing during the Coronavirus (COVID-19) pandemic.
The assay is engineered with:
- Dual target assay for RdRp and N-genes
- Qualitative detection of nucleic acids from SARS-CoV-2
- maxRatio data analysis removes operator subjectivity
- The Abbott RealTime SARS-CoV-2 assay in combination with the RealTime m2000 system allow scalable, automated process for flexible testing volume (24-96 samples) and up to 470 patient samples in 24 hours.
